Robin Norris MD MS, MPH
Associate Professor, Cincinnati Children's Hospital Medical Center
Join to View Full Profile
3333 Burnet AveMLC#7018Cincinnati, OH 45229
Phone+1 513-517-2067
Fax+1 513-636-3549
Dr. Norris is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2005 - 2008
University of California (San Francisco)Residency, Pediatrics, 2001 - 2004
Perelman School of Medicine at the University of PennsylvaniaClass of 2001
Certifications & Licensure
CA State Medical License 2003 - Present
OH State Medical License 2012 - 2028
IN State Medical License 2022 - 2023
KY State Medical License 2021 - 2023
PA State Medical License 2005 - 2012
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved Dose.Jonathan D Bender, Lauren Pommert, Lori R Backus, Andrea Bidwell, Courtney Blank
Pediatric Blood & Cancer. 2026-06-01 - Pain, Internalizing Symptoms, Posttraumatic Stress, and Alcohol Use Among Young Adult Survivors of Cancer.Kimberly L Klages, Julia K Herriott, Gabriella Breen, Robin E Norris, Sarah J Beal
Pediatric Blood & Cancer. 2026-04-01 - Patient-Level Barriers and Facilitators to Inpatient Physical Therapy in Adolescents and Young Adults With a Hematological Malignancy: A Qualitative Study.Jennifer A Kelleher, Jennifer L Bernstein, Katia M Crisler, Julia K Herriott, Kimberly L Klages
Pediatric Blood & Cancer. 2026-04-01
Abstracts/Posters
- V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute LeukemiaRobin Norris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaRobin Norris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Old English, New TechnologyOctober 13th, 2017
66: Balancing Private Practice and ParentingMarch 17th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
